Presentation is loading. Please wait.

Presentation is loading. Please wait.

Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J

Published byAili Pesonen Modified over 6 years ago

Similar presentations

Presentation on theme: "Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J"— Presentation transcript:

1 Prophylactic Use of Factor IX Concentrate in a Jehovah's Witness Patient 
Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J. Molinaro, PhD, MT, Fania Szlam, MMSc, Edward P. Chen, MD, Kenichi A. Tanaka, MD, MS  The Annals of Thoracic Surgery  Volume 88, Issue 5, Pages (November 2009) DOI: /j.athoracsur Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Hemostatic interventions, and changes in hematocrit, platelet count and international normalized ratio. Shaded area represents the duration of cardiopulmonary bypass. (A = antithrombin; B = Bebulin [Baxter Healthcare Corp, Westlake Village, CA]; C = cryoprecipitate; P = protamine; R = re-transfusion of autologous blood; rFVIIa = recombinant factor VIIa [Novoseven; NovoNordisk, Bagsbaerd, Denmark]). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J"

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,
Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J

Daniel Bolliger, MD, Gautam Sreeram, MD, Alexander Duncan, MD, Ross J
Effusive Tuberculous Pericarditis

Effusive Tuberculous Pericarditis
The STS National Database

The STS National Database
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G

Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.
Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S

Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S
Anaerobic Metabolism During Cardiopulmonary Bypass: Predictive Value of Carbon Dioxide Derived Parameters  Marco Ranucci, MD, Giuseppe Isgrò, MD, Federica.

Anaerobic Metabolism During Cardiopulmonary Bypass: Predictive Value of Carbon Dioxide Derived Parameters  Marco Ranucci, MD, Giuseppe Isgrò, MD, Federica.
Autologous Platelet-Rich Plasma Reduces Transfusions During Ascending Aortic Arch Repair: A Prospective, Randomized, Controlled Trial  Shao Feng Zhou,

Autologous Platelet-Rich Plasma Reduces Transfusions During Ascending Aortic Arch Repair: A Prospective, Randomized, Controlled Trial  Shao Feng Zhou,
Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes  Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes  Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.
Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery  Jason Brase, MS, Brooke Finger, MS,

Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery  Jason Brase, MS, Brooke Finger, MS,
Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V

Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V
Denton A. Cooley, August 22, 1920, to November 18, 2016

Denton A. Cooley, August 22, 1920, to November 18, 2016
Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients  Faraz Kerendi, MD, John D. Puskas,

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients  Faraz Kerendi, MD, John D. Puskas,
FDA Perspective on Clinical Trial Design for Cardiovascular Devices

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Similar presentations

Ads by Google